# Ardent Health, Inc.: filings ARDT · NYSE · CIK 1756655 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ardt.md) · [Financials](/companies/ardt/financials.md) · [Filings](/companies/ardt/filings.md) · [Insiders](/companies/ardt/insiders.md) ## Reports and events: 40 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 70, 8-K 22, 3 19, 10-Q 7, CORRESP 6, UPLOAD 6, S-1/A 5, 144 4, DRSLTR 4, DRS 3, SEC STAFF LETTER 3, 10-K 2, ARS 2, DEF 14A 2, DEFA14A 2, DRS/A 2, EFFECT 2, S-1 2, SC 13G 2, 424B2 1, 424B4 1, 8-A12B 1, ARS/A 1, CERT 1, RW 1, S-3 1, S-8 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 16:42 ET | [8-K](/filings/0001104659-26-118499.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-118499 | | 2026-09-04 | 16:16 ET | [8-K](/filings/0001628280-26-060735.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-060735 | | 2026-08-10 | 16:07 ET | [10-Q](/filings/0001628280-26-055215.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055215 | | 2026-08-04 | 16:16 ET | [8-K](/filings/0001628280-26-052598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052598 | | 2026-06-30 | 16:33 ET | [8-K](/filings/0001628280-26-046247.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-046247 | | 2026-06-02 | 16:23 ET | [8-K](/filings/0001193125-26-253567.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-253567 | | 2026-05-26 | 16:37 ET | [8-K](/filings/0001628280-26-038152.md) | 5.07 Shareholder vote results | 0001628280-26-038152 | | 2026-05-06 | 16:19 ET | [10-Q](/filings/0001628280-26-031299.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031299 | | 2026-05-05 | 16:15 ET | [8-K](/filings/0001628280-26-030552.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030552 | | 2026-04-08 | 16:17 ET | [DEF 14A](/filings/0001628280-26-024244.md) | Proxy statement, period 2026-05-20 | 0001628280-26-024244 | | 2026-03-27 | 16:15 ET | [8-K](/filings/0001628280-26-021738.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-021738 | | 2026-03-16 | 16:13 ET | [10-K](/filings/0001628280-26-018174.md) | Annual report, period 2025-12-31 | 0001628280-26-018174 | | 2026-03-04 | 16:16 ET | [8-K](/filings/0001628280-26-014640.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-014640 | | 2025-11-18 | 16:14 ET | [8-K](/filings/0001628280-25-052879.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-052879 | | 2025-11-14 | 16:14 ET | [10-Q](/filings/0001628280-25-052362.md) | Quarterly report, period 2025-09-30 | 0001628280-25-052362 | | 2025-11-12 | 16:32 ET | [8-K](/filings/0001628280-25-051634.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051634 | | 2025-09-23 | 16:32 ET | [8-K](/filings/0001628280-25-042486.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-042486 | | 2025-08-06 | 16:37 ET | [10-Q](/filings/0001756655-25-000018.md) | Quarterly report, period 2025-06-30 | 0001756655-25-000018 | | 2025-08-05 | 16:30 ET | [8-K](/filings/0001756655-25-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001756655-25-000013 | | 2025-06-20 | 16:48 ET | [8-K](/filings/0001756655-25-000009.md) | 5.02 Departure or appointment of officers or directors | 0001756655-25-000009 | | 2025-05-23 | 16:30 ET | [8-K](/filings/0001628280-25-027604.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-027604 | | 2025-05-07 | 16:31 ET | [10-Q](/filings/0001628280-25-023210.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023210 | | 2025-05-06 | 16:30 ET | [8-K](/filings/0001628280-25-022722.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022722 | | 2025-04-08 | 16:47 ET | [DEF 14A](/filings/0001628280-25-017085.md) | Proxy statement, period 2024-12-31 | 0001628280-25-017085 | | 2025-04-03 | 17:30 ET | [8-K](/filings/0001628280-25-016620.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-016620 | | 2025-03-31 | 16:31 ET | [8-K](/filings/0001628280-25-015672.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-015672 | | 2025-02-27 | 16:46 ET | [10-K](/filings/0001628280-25-008727.md) | Annual report, period 2024-12-31 | 0001628280-25-008727 | | 2025-02-26 | 16:30 ET | [8-K](/filings/0001628280-25-008185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008185 | | 2025-01-13 | 16:34 ET | [8-K](/filings/0001628280-25-001368.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001368 | | 2024-11-07 | 16:32 ET | [10-Q](/filings/0001756655-24-000017.md) | Quarterly report, period 2024-09-30 | 0001756655-24-000017 | | 2024-11-06 | 17:22 ET | [8-K](/filings/0001756655-24-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001756655-24-000010 | | 2024-08-14 | 17:05 ET | [10-Q](/filings/0001628280-24-037278.md) | Quarterly report, period 2024-06-30 | 0001628280-24-037278 | | 2024-08-14 | 16:31 ET | [8-K](/filings/0001628280-24-037235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-037235 | | 2024-07-15 | 06:05 ET | [S-1/A](/filings/0001193125-24-178802.md) | Registration statement, amended | 0001193125-24-178802 | | 2024-07-10 | 16:39 ET | [S-1/A](/filings/0001193125-24-177285.md) | Registration statement, amended | 0001193125-24-177285 | | 2024-07-08 | 17:31 ET | [S-1/A](/filings/0001193125-24-176379.md) | Registration statement, amended | 0001193125-24-176379 | | 2024-06-21 | 17:30 ET | [S-1](/filings/0001193125-24-165883.md) | Registration statement | 0001193125-24-165883 | | 2019-03-06 | 16:36 ET | [S-1/A](/filings/0001193125-19-065643.md) | Registration statement, amended | 0001193125-19-065643 | | 2018-12-21 | 13:14 ET | [S-1/A](/filings/0001193125-18-355936.md) | Registration statement, amended | 0001193125-18-355936 | | 2018-12-04 | 15:56 ET | [S-1](/filings/0001193125-18-342132.md) | Registration statement | 0001193125-18-342132 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.